LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Routine Donor Screening Revealed Acute Usutu Virus

By LabMedica International staff writers
Posted on 20 Apr 2017
Print article
Image: The cobas TaqScreen WNV test: a real-time polymerase chain reaction (PCR) test to detect West Nile virus (WNV) RNA in plasma from blood, organ and tissue donor (Photo courtesy of Roche Diagnostics).
Image: The cobas TaqScreen WNV test: a real-time polymerase chain reaction (PCR) test to detect West Nile virus (WNV) RNA in plasma from blood, organ and tissue donor (Photo courtesy of Roche Diagnostics).
Usutu virus (USUV) an Old World flavivirus included in the Japanese encephalitis virus (JEV) antigenic complex is transmitted by mosquitoes to birds that act as the main amplifying hosts, while humans are considered incidental or dead-end hosts.

USUV can cause Usutu fever in humans with mild to severe symptoms characterized by fever, rash, jaundice, headache, nuchal rigidity, hand tremor, and hyperreflexia. Humans were considered incidental hosts with very low prevalence, but recent data from Italy indicated that human USUV infection may not be a sporadic event and is more frequent than West Nile Virus (WNV).

Scientists at the Bernhard Nocht Institute for Tropical Medicine and their colleagues followed up blood donors being routinely screened for WNV between 1 June and 31 December 2016. There were 13,023 blood donations from the University Hospital Aachen.

In a plasma pool of 16 donors, the scientists detected WNV-positive (threshold cycle, Ct: 40.5) using cobas TaqScreen WNV Test with a sensitivity of 206.4 copies/mL per single donation. The blood donor was a German woman in her late 20s, without any travel history outside Germany in the previous seven months. Furthermore, she had not left the Aachen region at all in the three months prior to blood donation. The healthy donor had not experienced any illness or symptoms in the six weeks before donation. She reported several mosquito bites before the donation.

The team extracted RNA of plasma and urine samples were tested for the presence of flavivirus RNA with pan-flavivirus real-time reverse transcription–polymerase chain reaction (RT-PCR). A positive PCR result was obtained with RNA from the plasma sample and direct Sanger sequencing of the PCR amplicon showed USUV nucleic acid sequence. Attempts to isolate USUV in cell culture using the donor plasma were not successful.

The concentrated and purified RNA was further subjected to deep sequencing using in-house next-generation sequencing pipeline in order to obtain larger fragments of the USUV genome. Thus, the scientists were able to successfully recover about 60% of the USUV polyprotein gene. USUV from the donor plasma showed 99% homology with those found in the birds during the 2016 epizootics corresponding with the same region from where the donor originated.

The authors concluded that during the ongoing USUV epizootics in Germany, blood transfusion services, public health authorities and clinicians should be aware of increased human USUV infections. The study was published on April 6, 2017, in the journal Eurosurveillance.

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.